·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1840¸í ¹èÃ⡦Ãæ³²´ë ¼Õ¸íÈÆ¡¤´ë°¡´ë ±è¿ìÁø ¼ö¼® ±â»çÀÔ·Â : 22.02.17 16:14:29 4 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, ÇÕ°ÝÀÚ ¹ßÇ¥...ÇÕ°Ý·ü 92.3% [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¾à´ë»ý 1840¸íÀÌ ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 92.3%·Î Áö³ÇØ 91.0% ´ëºñ 1.3%p Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ¼ö¼®ÇÕ°ÝÀº Ãæ³²´ë ¼Õ¸íÈÆ, ´ë°¡´ë ±è¿ìÁø¾¾°¡ °øµ¿À¸·Î Â÷ÁöÇß´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ÀÌÀ±¼º)Àº Áö³´Þ 21ÀÏ ¼¿ï µî Àü±¹ 5°³ Áö¿ª, 6°³ ½ÃÇèÀå¿¡¼ ½ÃÇèµÈ 'Á¦73ȸ ¾à»ç±¹½Ã ÇÕ°ÝÀÚ'¸¦ ¿À´Ã(17ÀÏ) ¹ßÇ¥Çß´Ù. À̹ø ±¹½Ã¿¡´Â 1993¸íÀÌ ÀÀ½ÃÇßÀ¸¸ç ÀÌ °¡¿îµ¥ 1840¸íÀÌ ÇÕ°ÝÇß´Ù. ¼ö¼®ÇÕ°ÝÀÚµéÀº 350Á¡ ¸¸Á¡¿¡ 313Á¡(89.4Á¡/100Á¡ ȯ»ê±âÁØ)À» ¹Þ¾Ò´Ù. ÇÑÆí ¾à»ç ±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ¸ç ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ¼º£ÀÌ Âü¿© GO À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÇԾȰøÀå Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ¾îÈÞ Á¤¿øÀ» ÇÕ°Ý·üÀ» ÀúµûÀ§·Î Á¶ÀýÇÏ´Â Àü¹®Á÷ÀÌ ¾îµø³Ä ¾îÈÞ ¿åÃijª¿À³× ÁøÂ¥ 22.02.18 12:14:28 0 ¼öÁ¤ »èÁ¦ 2 2 ÃÖ¾à»ç 8x 9x Çйø¶§¾ß~~ ºÐ¾÷Àü¿¡ Àǻ縸ÅÀÇ Á÷´Éµµ ÀÖ¾ú°í µ·µµ ¾µ¾î ¸ð¾Ò´ÙÁö¸¸;; Áö±Ý 1x ÇйøµéÀº »óÀ§ 2~1%¿¡ ÀÇ»ç¶û Á¤¸» ÇѲýÂ÷ÀÌ ¼ö´ÉÁ¡¼öÀϰǵ¥;; ¾à»çÇö½ÇÀ» ¾Ë°Ô µÇ´Â¼ø°£ ÀÚ±«°¨ ¾öû³¯µí 22.02.17 17:43:32 2 ¼öÁ¤ »èÁ¦ 5 4 ¤· ¤· ÀÌÁ¦ ÇÕ°Ý·üÁ» Á¶ÀýÇÒ¶§¾Æ´Ñ°¡¿ä..? ³Ê¹«ÇÏ³×¿ä ¿¡Çô 22.02.17 17:29:55 0 ¼öÁ¤ »èÁ¦ 3 1 ÇÕ°Ý·ü ºÁ¶ó ¤»¤» 1234 92%? ¾îÀÌ°¡¾ø³× ¿¹ºñ ¹é¼öµé ÇÕ°Ý ÃàÇϵ帳´Ï´Ù ^^ 22.02.17 16:50:54 2 ¼öÁ¤ »èÁ¦ 7 12 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1840¸í ¹èÃ⡦Ãæ³²´ë ¼Õ¸íÈÆ¡¤´ë°¡´ë ±è¿ìÁø ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1840¸í ¹èÃ⡦Ãæ³²´ë ¼Õ¸íÈÆ¡¤´ë°¡´ë ±è¿ìÁø ¼ö¼® ±â»çÀÔ·Â : 22.02.17 16:14:29 4 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, ÇÕ°ÝÀÚ ¹ßÇ¥...ÇÕ°Ý·ü 92.3% [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¾à´ë»ý 1840¸íÀÌ ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 92.3%·Î Áö³ÇØ 91.0% ´ëºñ 1.3%p Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ¼ö¼®ÇÕ°ÝÀº Ãæ³²´ë ¼Õ¸íÈÆ, ´ë°¡´ë ±è¿ìÁø¾¾°¡ °øµ¿À¸·Î Â÷ÁöÇß´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ÀÌÀ±¼º)Àº Áö³´Þ 21ÀÏ ¼¿ï µî Àü±¹ 5°³ Áö¿ª, 6°³ ½ÃÇèÀå¿¡¼ ½ÃÇèµÈ 'Á¦73ȸ ¾à»ç±¹½Ã ÇÕ°ÝÀÚ'¸¦ ¿À´Ã(17ÀÏ) ¹ßÇ¥Çß´Ù. À̹ø ±¹½Ã¿¡´Â 1993¸íÀÌ ÀÀ½ÃÇßÀ¸¸ç ÀÌ °¡¿îµ¥ 1840¸íÀÌ ÇÕ°ÝÇß´Ù. ¼ö¼®ÇÕ°ÝÀÚµéÀº 350Á¡ ¸¸Á¡¿¡ 313Á¡(89.4Á¡/100Á¡ ȯ»ê±âÁØ)À» ¹Þ¾Ò´Ù. ÇÑÆí ¾à»ç ±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ¸ç ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ¼º£ÀÌ Âü¿© GO À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÇԾȰøÀå Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â ¾îÈÞ Á¤¿øÀ» ÇÕ°Ý·üÀ» ÀúµûÀ§·Î Á¶ÀýÇÏ´Â Àü¹®Á÷ÀÌ ¾îµø³Ä ¾îÈÞ ¿åÃijª¿À³× ÁøÂ¥ 22.02.18 12:14:28 0 ¼öÁ¤ »èÁ¦ 2 2 ÃÖ¾à»ç 8x 9x Çйø¶§¾ß~~ ºÐ¾÷Àü¿¡ Àǻ縸ÅÀÇ Á÷´Éµµ ÀÖ¾ú°í µ·µµ ¾µ¾î ¸ð¾Ò´ÙÁö¸¸;; Áö±Ý 1x ÇйøµéÀº »óÀ§ 2~1%¿¡ ÀÇ»ç¶û Á¤¸» ÇѲýÂ÷ÀÌ ¼ö´ÉÁ¡¼öÀϰǵ¥;; ¾à»çÇö½ÇÀ» ¾Ë°Ô µÇ´Â¼ø°£ ÀÚ±«°¨ ¾öû³¯µí 22.02.17 17:43:32 2 ¼öÁ¤ »èÁ¦ 5 4 ¤· ¤· ÀÌÁ¦ ÇÕ°Ý·üÁ» Á¶ÀýÇÒ¶§¾Æ´Ñ°¡¿ä..? ³Ê¹«ÇÏ³×¿ä ¿¡Çô 22.02.17 17:29:55 0 ¼öÁ¤ »èÁ¦ 3 1 ÇÕ°Ý·ü ºÁ¶ó ¤»¤» 1234 92%? ¾îÀÌ°¡¾ø³× ¿¹ºñ ¹é¼öµé ÇÕ°Ý ÃàÇϵ帳´Ï´Ù ^^ 22.02.17 16:50:54 2 ¼öÁ¤ »èÁ¦ 7 12 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1840¸í ¹èÃ⡦Ãæ³²´ë ¼Õ¸íÈÆ¡¤´ë°¡´ë ±è¿ìÁø ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1840¸í ¹èÃ⡦Ãæ³²´ë ¼Õ¸íÈÆ¡¤´ë°¡´ë ±è¿ìÁø ¼ö¼® ±â»çÀÔ·Â : 22.02.17 16:14:29 4 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, ÇÕ°ÝÀÚ ¹ßÇ¥...ÇÕ°Ý·ü 92.3% [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¾à´ë»ý 1840¸íÀÌ ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 92.3%·Î Áö³ÇØ 91.0% ´ëºñ 1.3%p Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ¼ö¼®ÇÕ°ÝÀº Ãæ³²´ë ¼Õ¸íÈÆ, ´ë°¡´ë ±è¿ìÁø¾¾°¡ °øµ¿À¸·Î Â÷ÁöÇß´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ÀÌÀ±¼º)Àº Áö³´Þ 21ÀÏ ¼¿ï µî Àü±¹ 5°³ Áö¿ª, 6°³ ½ÃÇèÀå¿¡¼ ½ÃÇèµÈ 'Á¦73ȸ ¾à»ç±¹½Ã ÇÕ°ÝÀÚ'¸¦ ¿À´Ã(17ÀÏ) ¹ßÇ¥Çß´Ù. À̹ø ±¹½Ã¿¡´Â 1993¸íÀÌ ÀÀ½ÃÇßÀ¸¸ç ÀÌ °¡¿îµ¥ 1840¸íÀÌ ÇÕ°ÝÇß´Ù. ¼ö¼®ÇÕ°ÝÀÚµéÀº 350Á¡ ¸¸Á¡¿¡ 313Á¡(89.4Á¡/100Á¡ ȯ»ê±âÁØ)À» ¹Þ¾Ò´Ù. ÇÑÆí ¾à»ç ±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ¸ç ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ¼º£ÀÌ Âü¿© GO À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
¾îÈÞ Á¤¿øÀ» ÇÕ°Ý·üÀ» ÀúµûÀ§·Î Á¶ÀýÇÏ´Â Àü¹®Á÷ÀÌ ¾îµø³Ä ¾îÈÞ ¿åÃijª¿À³× ÁøÂ¥ 22.02.18 12:14:28 0 ¼öÁ¤ »èÁ¦ 2 2 ÃÖ¾à»ç 8x 9x Çйø¶§¾ß~~ ºÐ¾÷Àü¿¡ Àǻ縸ÅÀÇ Á÷´Éµµ ÀÖ¾ú°í µ·µµ ¾µ¾î ¸ð¾Ò´ÙÁö¸¸;; Áö±Ý 1x ÇйøµéÀº »óÀ§ 2~1%¿¡ ÀÇ»ç¶û Á¤¸» ÇѲýÂ÷ÀÌ ¼ö´ÉÁ¡¼öÀϰǵ¥;; ¾à»çÇö½ÇÀ» ¾Ë°Ô µÇ´Â¼ø°£ ÀÚ±«°¨ ¾öû³¯µí 22.02.17 17:43:32 2 ¼öÁ¤ »èÁ¦ 5 4 ¤· ¤· ÀÌÁ¦ ÇÕ°Ý·üÁ» Á¶ÀýÇÒ¶§¾Æ´Ñ°¡¿ä..? ³Ê¹«ÇÏ³×¿ä ¿¡Çô 22.02.17 17:29:55 0 ¼öÁ¤ »èÁ¦ 3 1 ÇÕ°Ý·ü ºÁ¶ó ¤»¤» 1234 92%? ¾îÀÌ°¡¾ø³× ¿¹ºñ ¹é¼öµé ÇÕ°Ý ÃàÇϵ帳´Ï´Ù ^^ 22.02.17 16:50:54 2 ¼öÁ¤ »èÁ¦ 7 12 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1840¸í ¹èÃ⡦Ãæ³²´ë ¼Õ¸íÈÆ¡¤´ë°¡´ë ±è¿ìÁø ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö